The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Neoplasm Proteins
Hierarchy: | ∟ ∟ ∟ Neoplasm Proteins 98 coordinate concepts5 subordinate concepts∟ ∟ ∟ ∟ ∟ ∟ Albumins | ∟ ∟ ∟ Amyloid | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Lectins | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Peptones | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Prions | ∟ ∟ ∟ ∟ ∟ ∟ ∟ Proteome | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Serpins | ∟ Silk | ∟ ∟ ∟ Thymosin | ∟ ∟ ∟ ∟ |
Broader terms: | |
Narrower terms: | |
Annotation: | IM & coord with specific protein (IM) + specific histol type (IM) + specific organ/neoplasms term (IM); Manual 24.4.4.4
X |
Scope note: | Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (TUMOR MARKERS, BIOLOGICAL) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
X |
activeMeSHYear*: | |
dateCreated*: | 1999-01-01X |
dateEstablished*: | 1963-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | SYSTEMX |
recordOriginator*: | NLMX |
Related term: | |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Kasvainproteiinit (fi) XProteínas de Neoplasias (es) πρωτεΐνες νεοπλάσματος (el) Tumorproteine (de) nádorové proteiny (cs) |
Share: |
Loading results...